Novo Nordisk A/S Common Stock (NVO)
EBITDA Margin
54.91%
TTM · Period ending:

NVO EBITDA Margin
Latest reported54.91%period ending
Latest reported54.91%period ending
NVO TTM EBITDA Margin (17.72% → 54.91%)
TTM ebitda margin
High-resolution chart · PNG
NVO ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 42.0619% | |
| 43.5214% | |
| 43.9352% | |
| 47.4154% | |
| 26.0493% | |
| 21.1277% | |
| 17.6353% | |
| 22.1562% | |
| 19.0191% | |
| 17.0931% | |
| 15.1455% | |
| 20.7391% | |
| 17.5314% | |
| 15.4202% | |
| 12.5654% | |
| 20.5614% | |
| 17.2724% | |
| 13.8701% | |
| 12.7514% | |
| 15.5593% | |
| 12.7527% | |
| 13.1733% | |
| 12.7631% | |
| 14.8793% | |
| 15.8423% | |
| 14.9209% | |
| 13.2827% | |
| 20.8408% | |
| 19.4532% | |
| 16.9478% | |
| 13.8493% | |
| 17.1051% | |
| 12.8082% | |
| 11.2273% | |
| 11.5209% | |
| 23.2724% | |
| 22.0456% | |
| 17.7838% | |
| 14.5705% | |
| 21.2524% | |
| 18.0301% | |
| 15.9738% | |
| 12.5849% | |
| 19.3612% | |
| 16.4734% | |
| 13.4525% | |
| 13.8529% | |
| 34.0471% | |
| 29.8318% | |
| 25.7227% | |
| 15.1345% | |
| 17.0119% | |
| 16.2338% | |
| 12.5625% | |
| 13.2629% | |
| 25.3114% | |
| 21.0078% | |
| 19.9738% | |
| 16.1143% | |
| 18.2829% | |
| 17.7189% |